Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.7400

-0.0142 (-1.88%)

At close: Feb 27, 2026, 4:00 PM EST

0.7546

+0.0146 (1.97%)

After-hours: Feb 27, 2026, 7:48 PM EST

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	17	21	90	109	177	296
Market Cap Growth	-18.03%	-76.68%	-16.79%	-38.51%	-40.33%	413.63%
Enterprise Value	11	19	73	77	130	182
Last Close Price	0.74	1.24	12.52	17.11	30.25	50.75
PB Ratio	0.21	0.27	1.22	1.19	1.71	2.23
P/TBV Ratio	-	-	-	4.92	5.19	4.67
Debt / Equity Ratio	0.02	0.02	0.00	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.06	-0.03	-0.04	-0.28	-0.40	-0.52
Net Debt / EBITDA Ratio	0.16	0.06	0.07	0.71	1.23	2.94
Net Debt / FCF Ratio	0.17	0.09	0.11	0.90	1.45	2.85
Quick Ratio	0.31	0.10	0.09	4.58	9.21	17.60
Current Ratio	0.99	0.62	0.40	5.95	9.84	18.29
Return on Equity (ROE)	-47.85%	-52.42%	-47.63%	-33.40%	-28.48%	-27.70%
Return on Assets (ROA)	-17.68%	-19.45%	-23.83%	-21.10%	-16.24%	-15.80%
Return on Capital Employed (ROCE)	-36.10%	-44.80%	-52.00%	-37.50%	-30.40%	-17.00%
Earnings Yield	-216.72%	-177.45%	-43.26%	-29.93%	-19.03%	-7.78%
FCF Yield	-210.38%	-125.87%	-31.17%	-26.73%	-16.04%	-8.19%
Buyback Yield / Dilution	-107.77%	-64.49%	-11.16%	-3.57%	-34.52%	-177.28%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q